An Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint

Part of paid clinical trials in Las Vegas, Nevada.

Sponsor
Ageless Biotech, Inc.
Study ID
NCT06485843
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
35 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • OA-SYS — DRUG
    OA-SYS is made of several types of cells obtained from fat tissue for the treatment of osteoarthritis.

Study Details

This study is being conducted to evaluate the safety and tolerability of OA-SYS in patients with moderate to severe OA of the knee joint.

Key Dates

Start date
May 21, 2025
Status verified
Sep 2025
Primary completion
Mar 31, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
400 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: OA-SYS
    Treatment with OA-SYS

Primary Outcome Measure

Presence of Adverse Events [ Time Frame: 52 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Orthopedic & Sports Medicine Institute of Las VegasLas VegasNevada89117
Randa Bascharon, DO

Find similar trials in Las Vegas, NV

By condition
Osteoarthritis (other)
By specialty
OrthopedicsMusculoskeletal disorders
By research site
Orthopedic & Sports Medicine Institute of Las Vegas· Las Vegas, NV

Related Studies